Digital Edition: MedTech Strategist January 2025

article image
ARTICLE SUMMARY:

MVM Ventures' Hugo Harrod on strategies for successful exits; start-ups tackle men's reproductive health; our expert panel discusses robotics' potential to improve outcomes and how best to meet that potential; first-mover Inspire Medical's success in the obstructive sleep apnea market has spawned a new generation of medtechs pursuing hypoglossal nerve stimulation for OSA; Pacira's successful battle for better non-opioid drug and device reimbursement. Plus profiles of Samay and SwiftDuct.

×



This article is restricted to subscribers only.

Sign in to continue reading.

Questions?

We're here to help! Please contact us at: